EntryPoint Capital’s Pfizer PFE Stock Holding History

EntryPoint Capital's PFE Position: Q2 2026 in Review

EntryPoint Capital opened a new position in Pfizer (PFE) in Q2 2026: 40,976 shares worth $987K. The stake represents 0.24% of the portfolio and ranks #83 among its holdings. This is a return to the name: EntryPoint Capital previously reported a position in PFE as recently as Q3 2025.

EntryPoint Capital first reported a position in PFE in Q4 2023 and has held it in 4 quarters since. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

• EntryPoint Capital held 40,976 shares of Pfizer worth $987K as of Q2 2026.
• Pfizer was a new EntryPoint Capital position in Q2 2026.
• Pfizer made up 0.24% of EntryPoint Capital's portfolio in Q2 2026, its #83 holding.
• EntryPoint Capital first reported a position in Pfizer in Q4 2023 and has held it in 4 quarters since.
• 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.